IDYA vs. IR
IDYA (IDEAYA Biosciences, Inc.) and IR (Ingersoll-Rand Plc) are both stocks. IDYA operates in Biotechnology (Healthcare), while IR operates in Specialty Industrial Machinery (Industrials). Over the past 5 years, IDYA returned 9.49%/yr vs 10.10%/yr for IR. At a 0.23 correlation, their price movements are largely independent.
Performance
IDYA vs. IR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDYA achieves a -0.98% return, which is significantly higher than IR's -3.21% return.
IDYA
- 1D
- 9.61%
- 1M
- 17.63%
- YTD
- -0.98%
- 6M
- -3.58%
- 1Y
- 57.96%
- 3Y*
- 11.82%
- 5Y*
- 9.49%
- 10Y*
- —
IR
- 1D
- -1.58%
- 1M
- 8.08%
- YTD
- -3.21%
- 6M
- -5.86%
- 1Y
- -6.36%
- 3Y*
- 6.65%
- 5Y*
- 10.10%
- 10Y*
- —
IDYA vs. IR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
IDYA IDEAYA Biosciences, Inc. | -0.98% | 34.51% | -27.77% | 95.82% | -23.14% | 68.86% | 86.67% | -46.43% |
IR Ingersoll-Rand Plc | -3.21% | -12.34% | 17.06% | 48.21% | -15.41% | 35.85% | 24.21% | 8.31% |
Correlation
The correlation between IDYA and IR is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since May 23, 2019 | 0.23 |
Fundamentals
IDYA:
-$1.58
IR:
$1.96
IDYA:
13.50
IR:
2.95
IDYA:
$225.27M
IR:
$7.78B
IDYA:
$215.25M
IR:
$2.98B
IDYA:
-$157.90M
IR:
$1.55B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDYA vs. IR — Risk / Return Rank
IDYA
IR
IDYA vs. IR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and Ingersoll-Rand Plc (IR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IDYA | IR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.37 | ||
| Sortino ratioReturn per unit of downside risk | +1.88 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.00 | +0.23 |
| Calmar ratioReturn relative to maximum drawdown | 2.15 | -0.21 | +2.36 |
| Martin ratioReturn relative to average drawdown | 4.76 | -0.46 | +5.22 |
Loading charts...
Drawdowns
IDYA vs. IR - Drawdown Comparison
The maximum IDYA drawdown since its inception was -78.36%, which is greater than IR's maximum drawdown of -50.27%. Use the drawdown chart below to compare losses from any high point for IDYA and IR.
Loading charts...
Drawdown Indicators
| IDYA | IR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.36% | -50.27% | -28.09% |
Max Drawdown (1Y)Largest decline over 1 year | -27.10% | -30.56% | +3.46% |
Max Drawdown (3Y)Largest decline over 3 years | -69.23% | -36.62% | -32.61% |
Max Drawdown (5Y)Largest decline over 5 years | -69.42% | -36.62% | -32.80% |
Current DrawdownCurrent decline from peak | -27.37% | -27.14% | -0.23% |
Average DrawdownAverage peak-to-trough decline | -32.37% | -12.87% | -19.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.22% | 13.91% | -1.69% |
Volatility
IDYA vs. IR - Volatility Comparison
IDEAYA Biosciences, Inc. (IDYA) has a higher volatility of 20.73% compared to Ingersoll-Rand Plc (IR) at 9.65%. This indicates that IDYA's price experiences larger fluctuations and is considered to be riskier than IR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDYA | IR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.73% | 9.65% | +11.08% |
Volatility (6M)Calculated over the trailing 6-month period | 35.84% | 25.65% | +10.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.32% | 33.67% | +15.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.41% | 30.11% | +29.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 74.34% | 34.35% | +39.99% |
Dividends
IDYA vs. IR - Dividend Comparison
IDYA has not paid dividends to shareholders, while IR's dividend yield for the trailing twelve months is around 0.10%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IDYA IDEAYA Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IR Ingersoll-Rand Plc | 0.10% | 0.10% | 0.09% | 0.10% | 0.15% | 0.03% | 0.00% | 5.78% |
Financials
IDYA vs. IR - Financials Comparison
This section allows you to compare key financial metrics between IDEAYA Biosciences, Inc. and Ingersoll-Rand Plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IDYA and IR have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDYA has higher volatility (20.73%) compared to IR (9.65%). In terms of maximum drawdown, IDYA dropped -78.36% vs IR's -50.27%.
IDYA currently has the higher Sharpe Ratio (1.18 vs -0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDYA and IR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer